A 4-Year Prospective Study on Anti-fungal and Reserved Antimicrobial Drugs under Antimicrobial Stewardship Program
4★, 2, 3★ Corresponding author
- 2KB Institute of Pharmaceutical Education and Research, Gandhinagar, Gujarat, INDIA.
- 3Department of Microbiologist, CIMS Hospital, Ahmedabad, Gujarat, INDIA.
- 4Department of Microbiology, Clinical Pharmacologist, CIMS Hospital, Ahmedabad, Gujarat, INDIA.
CORRESPONDENCE
Ketan Kailash Khelwade
Department of Microbiology, Clinical Pharmacologist, CIMS Hospital, Ahmedabad, Gujarat, INDIA.
Received: 02-09-2021; Revised: 24-11-2021; Accepted: 09-03-2022.
Volume 12, Issue 2 · pp. 242-246 · 2022 · DOI: 10.5530/ijpi.2022.2.43
ABSTRACT
Introduction: In 2018 and 2021, CIMS hospital conducted an audit to analyse the quality of antifungal use. We conducted a follow-up audit after four years of the antifungal stewardship programme (AFS) to evaluate the program’s long-term effects. We assessed antifungal usage in Medical & surgical Patients receiving systemic antifungals using a pre set score. Antibiotics and its classes designated as antimicrobial reserved products are intended to be used only in the treatment of confirmed or suspected infections caused by multidrug-resistant organisms.Materials and Methods: The research was conducted in a medical & surgical unit at tertiary care hospital during a four-year period. The sensitivity pattern was identified after the laboratory data were processed. Some of the newer AMs were labelled as “Reserve,” requiring the completion of an authorization form prior to prescription.Results: Patients treated with antimicrobial drugs in medical and ICU wards were assessed. The results of both the audits revealed that there was a decrease in the irrational cases of both reserved antimicrobial and antifungal cases in successive years. The year 2020 showed fewer irrational cases of antifungals.Conclusion: With time the use of correct dosage regimen, proper route of administration and proper handling of patients has led to decrease in the irrational cases of antimicrobials.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Khelwade, K. K., D, S., & S, B. (2022). A 4-Year Prospective Study on Anti-fungal and Reserved Antimicrobial Drugs under Antimicrobial Stewardship Program. International Journal of Pharmaceutical Investigation, 12(2), 242-246. https://doi.org/10.5530/ijpi.2022.2.43
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
